Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulīte(University of Zurich), Emmanuella Guenova(Johannes Kepler University of Linz)
Cited by 62
Related Papers
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
|British Journal of Dermatology|2018|235
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
|Blood|2021|170
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
|European Journal of Cancer|2023|164
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
|Nature Communications|2024|14